One-Quarter Of Part D Drugs Are Rebated To Plans, Rep. Waxman Reports

Twenty-seven percent of the various drug products used by Medicare Part D enrollees are subject to manufacturer rebates that reduce their price, according to a survey of the leading 12 Part D insurance providers

More from Archive

More from Pink Sheet